BlackRock Fund Advisors’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$144M Buy
1,895,542
+63,731
+3% +$4.86M 0.03% 902
2016
Q3
$153M Buy
1,831,811
+77,014
+4% +$6.42M 0.03% 735
2016
Q2
$145M Buy
1,754,797
+85,280
+5% +$7.03M 0.03% 702
2016
Q1
$127M Sell
1,669,517
-14,644
-0.9% -$1.11M 0.03% 765
2015
Q4
$135M Buy
1,684,161
+69,142
+4% +$5.56M 0.03% 733
2015
Q3
$103M Buy
1,615,019
+1,234
+0.1% +$78.4K 0.03% 883
2015
Q2
$114M Buy
1,613,785
+90,319
+6% +$6.35M 0.03% 889
2015
Q1
$121M Buy
1,523,466
+156,222
+11% +$12.4M 0.03% 834
2014
Q4
$87M Sell
1,367,244
-24,730
-2% -$1.57M 0.02% 1054
2014
Q3
$83.2M Buy
1,391,974
+17,058
+1% +$1.02M 0.02% 991
2014
Q2
$73.6M Buy
1,374,916
+62,346
+5% +$3.34M 0.02% 1129
2014
Q1
$79.2M Sell
1,312,570
-69,507
-5% -$4.19M 0.02% 1041
2013
Q4
$73.3M Buy
1,382,077
+103,569
+8% +$5.49M 0.02% 1094
2013
Q3
$59.1M Buy
1,278,508
+59,395
+5% +$2.75M 0.02% 1193
2013
Q2
$50M Buy
+1,219,113
New +$50M 0.02% 1204